A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting

• Published in: BMC cardiovascular disorders Vol. 17; no. 1; p. 204
• Main Authors: Du, Xin, Guo, Lizhu, He, Xiaonan, Jia, Yu, Wu, Jiahui, Long, Deyong, Yu, Ronghui, Sang, Caihua, Liu, Xiaohui, Yin, Hongjun, Xuan, Jianwei, Dong, Jianzeng, Ma, Changsheng
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 27.07.2017; BioMed Central; BMC
• Subjects: Aged; Anti-Arrhythmia Agents - adverse effects; Anti-Arrhythmia Agents - therapeutic use; Anti-arrhythmic drugs; Atrial fibrillation; Atrial Fibrillation - diagnosis; Atrial Fibrillation - physiopathology; Atrial Fibrillation - therapy; Cardiac arrhythmia; Care and treatment; Catheter ablation; Catheter Ablation - adverse effects; Catheters; China; Chinese; Comparative analysis; Data analysis; Disease; Disease-Free Survival; Drug dosages; Drug therapy; Enrollments; Female; Fibrillation; Heart Conduction System - drug effects; Heart Conduction System - physiopathology; Heart Conduction System - surgery; Heart failure; Heart Rate - drug effects; Hospitals; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Mortality; Multivariate Analysis; Patient outcomes; Patients; Propensity Score; Proportional Hazards Models; Prospective Studies; Quality of Life; Radiofrequency ablation; Recurrence; Risk Factors; Time Factors; Treatment Outcome; China; Anti-arrhythmic drugs; Chinese; Atrial fibrillation; Catheter ablation; Quality of life

Studies have demonstrated that catheter ablation of atrial fibrillation is associated with better rhythm control than drug therapy. The present study aimed to assess the clinical outcomes and health-related quality of life of ablation therapy in a real world setting. A prospective, non-randomized, s...